This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (28)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

OTTO SAPHIR, M.D.; NATHAN A. COHEN, M.D.

AMA Arch Intern Med. 1959;104(5):748-762.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In many texts on pathology and internal medicine, and even in recent publications, malignant nephrosclerosis is often regarded as the anatomical counterpart of malignant hypertension. Studying a number of such reports, we became aware that malignant nephrosclerosis cannot possibly be one single or one well-defined entity, since the descriptions of such kidneys are very much at variance, and since the various cases present somewhat different findings. As a matter of fact, changes characteristic of not only one but of several diseases may be found in some instances in one kidney. In recent years, there has been a guarded, but generally progressive, acceptance of pyelonephritis as a factor in the pathogenesis of malignant hypertension.¹,² Recently, also, emphasis has been placed on the insidious course and the high incidence of urinary tract infections.^3-11 However, even in recent publications, the kidney lesions of most cases of malignant hypertension remain ascribed . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

From the Department of Pathology, Michael Reese Hospital.

Footnotes
Submitted for publication Feb. 23, 1959.

This research was supported by the Lebold Memorial Fund and the Byron C. Sharpe Fund.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?